Skip to main content
OpenTrials
Completed

NCT Number: NCT04606823

Ponto Implantation Using a Minimally Invasive Surgical Technique

This multi-centre study funded by Oticon Medical AB will be conducted at seven hospitals across Europe (UK, Sweden, Denmark and the Netherlands). In total, 50 adult patients with a hearing loss that are already planned for treatment with a percutaneous (through the skin) bone-anchored hearing system (BAHS) will be included in the study.

The purpose of the study is to investigate the rate of successful BAHS use after implantation of the Ponto implant system using a minimally invasive surgical technique.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aalborg University Hospital, Aalborg, Denmark

Loading trial locations.

About this study

This multi-centre study funded by Oticon Medical AB will be conducted at seven hospitals across Europe (UK, Sweden, Denmark and the Netherlands). In total, 50 adult patients with a hearing loss that are already planned for treatment with a percutaneous (through the skin) bone-anchored hearing system (BAHS) will be included in the study.

The purpose of the study is to investigate the rate of successful BAHS use after implantation of the Ponto implant system using a minimally invasive surgical technique. The implant, coupled to a skin-penetrating abutment, is implanted in the bone behind the ear and is later loaded with a sound processor which transforms sound waves to sound vibrations that can be sent directly to the inner ear via the skull bone. The primary objective of this study is to investigate the proportion of implant/abutment complexes providing a reliable anchorage for a sound processor three months after implantation/surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Patient indicated for surgical intervention with a bone anchored hearing system
  • Signed informed consent
  • Adequate bone quality to allow for a Ponto implant insertion, as judged by the investigator, and an expected bone thickness above 5 mm, where no complications during surgery are expected
  • Skin thickness of 12 mm or less at the implant site

Exclusion criteria

  • Patient undergoing re-implantation
  • Patient who are unable or unwilling to follow investigational procedures/requirements, e.g. to complete quality of life scales
  • Known condition or previous treatment that could jeopardize skin condition and wound healing over time as judged by the investigator (e.g. uncontrolled diabetes, previous radiotherapy in the area of interest)
  • Known medical condition that contraindicate surgery as judged by the investigator
  • Known and/or planned pregnancy at time of surgery
  • Any other known condition that the investigator determines could interfere with compliance or investigation assessments
  • Simultaneous participation in another clinical investigation with pharmaceutical and/or medical device which might cause interference with investigation participation

Treatment and study plan

Minimally Invasive Surgery

Procedure

The subjects will be implanted with a bone anchored hearing system using a minimally invasive surgery.

Glasgow Benefit Inventory (GBI)

Other

A quality of life-questionnaire is to be completed by the subjects at one occasion.

Additional follow-up visits after surgery

Other

There are 1-3 additional follow-up visits after surgery (compared to the routine clinical practice of the surgeons/clinics).

Primary outcomes

  1. Number of Implants With Reliable Anchorage for a Sound Processor

    Time frame: 3 months after implant surgery

    The variables assessed to determine reliable anchorage in the study are implant survival and stability, skin reactions, skin overgrowth and pain preventing use of the sound processor. For a positive outcome of the primary endpoint (reliable anchorage), the implant should be in place and stable without any adverse skin reactions, skin overgrowth or pain preventing usage of the sound processor.

Secondary outcomes

  1. Number of Implants With Reliable Anchorage for a Sound Processor

    Time frame: 12 months after implant surgery

    The variables assessed to determine reliable anchorage in the study are implant survival and stability, skin reactions, skin overgrowth and pain preventing use of the sound processor. For a positive outcome (reliable anchorage), the implant should be in place and stable without any adverse skin reactions, skin overgrowth or pain preventing usage of the sound processor.

  2. Implant Survival

    Time frame: 12 months after implant surgery

    Implant survival will be assessed by the investigator by means of a Yes/No question: Implant in place [Yes/No]

  3. Implant Stability

    Time frame: 12 months after implant surgery

    Clinical assessment of implant stability by the investigator by means of a Yes/No question: Implant stable [Yes/No]

  4. Holgers Score Distribution

    Time frame: 9 days, 5 weeks, 3-, 6-, and 12 months after implant surgery, and unplanned visits

    Distribution of Holgers score ratings assigned by investigator across all study visits. The Holgers score is used to grade skin reactions around the skin-penetrating abutment on a scale from 0 to 4, where 0 indicates a reaction-free area whereas 4 indicates a severe infection often requiring removal of the implant.

    The results are presented based on Holgers score distribution across all study visits, as well as separate for each study visit and for unplanned visits.

  5. Max Holgers Score

    Time frame: 12 months after implant surgery

    Max Holgers score rating per patient across study visits. The Holgers score is used to grade skin reactions around the skin-penetrating abutment on a scale from 0 to 4, where 0 indicates a reaction-free area whereas 4 indicates a severe infection often requiring removal of the implant.

  6. Mild/Adverse Skin Reaction

    Time frame: 12 months after implant surgery

    Mild/Adverse skin reaction per patient across study visits, where adverse skin reaction is defined as Holgers ≥ 2 on at least one follow-up visit. The Holgers score is used to grade skin reactions around the skin-penetrating abutment on a scale from 0 to 4, where 0 indicates a reaction-free area whereas 4 indicates a severe infection often requiring removal of the implant.

  7. IPS (Inflammation, Pain, Skin Height) Scores

    Time frame: 9 days, 5 weeks, 3-, 6- and 12 months after implant surgery, and unplanned visits

    Distribution of IPS scores assigned by investigator across all study visits. The IPS scale is used to assess soft tissue status including inflammation (I), pain (P), and skin height (S) for a skin-penetrating implant, with scores ranging from 0 to 4 for the I-scale, and from 0 to 2 for the P- and S-scales. The IPS score is presented as [Ix Px Sx] with x being the individual score for each parameter. A higher score reflects a more severe complication.

    The results are presented based on IPS score distribution across all study visits, as well as separate for each study visit and unplanned visits.

  8. Wound Healing

    Time frame: 9 days, 5 weeks and 3 months after implant surgery, and unplanned visits

    Investigator assessment of wound being completely healed by means of a Yes/No question.

    The results are presented for each study visit and for unplanned visits.

  9. Skin Overgrowth

    Time frame: 9 days, 5 weeks, 3-, 6-, and 12 months after implant surgery, and unplanned visits

    Skin overgrowth over implant/abutment complex judged by the investigator by means of a Yes/No question.

    The results are presented for each study visit and for unplanned visits.

  10. Post-operative Events Around Abutment

    Time frame: 9 days, 5 weeks, 3-, 6-, and 12 months after implant surgery, and unplanned visits

    Assessment of post-operative events by investigator into five different categories: None, Bleeding and/or hematoma, Hair in-growth, Skin dehiscence around abutment, and Other.

    The results are presented based on post-operative event distribution across all study visits, as well as separate for each study visit and unplanned visits.

  11. Patient-perceived Presence of Pain Around Abutment

    Time frame: 9 days, 5 weeks, 3-, 6-, and 12 months after implant surgery, and unplanned visits

    Assessment of presence of patient-perceived pain by means of a Yes/No question to the subject.

  12. Patient-perceived Presence of Numbness Around Abutment

    Time frame: 9 days, 5 weeks, 3-, 6-, and 12 months after implant surgery, and unplanned visits

    Assessment of presence of patient-perceived numbness by means of a Yes/No question to the patient.

  13. Duration of Surgery

    Time frame: 3 months after implant surgery

    Length of surgery measured in minutes.

  14. Sound Processor Usage

    Time frame: 12 months after implant surgery

    Average sound processor usage time.

  15. Subjective Benefit After Surgery

    Time frame: 3 months after surgery

    The Glasgow Benefit Inventory (GBI) is a validated, 18-item patient-reported questionnaire that assesses changes in health-related quality-of-life following otorhinolaryngological (ENT) interventions. The questionnaire evaluates the perceived benefit after a procedure and generates a Total Score and three subscale scores: General (12 items), Social Support (3 items), and Physical Health (3 items). Each score ranges from -100 to +100, where positive values indicate improvement, negative values indicate deterioration, and zero reflects no change. The Total Score is calculated as the mean of all item scores (not a sum of subscale scores), while each subscale score is calculated as the mean of the items belonging to that subscale.

Sponsors and collaborators

Lead sponsor

Oticon Medical

Industry

Registry information

Official study title

Evaluation of Clinical Performance of Ponto Implantation Using a Minimally Invasive Surgical Technique - a Prospective Multicentre Study

Important dates

Study start
2020
Primary completion
2022
Study completion
2023
First posted
Oct 28, 2020
Registry last updated
Jan 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.